Corcept Therapeutics Incorporated (CORT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more
What's happening with CORT?
Powered by Yahoo ScoutCorcept Therapeutics (CORT) reported strong Q2 2026 earnings with $256.1 millionin revenue, surpassing expectations and prompting a raised revenue forecast. Despite this, the stock has faced a slight decline of 1.2%since the last earnings report due to volatility and valuation concerns.
- Previous Close
112.80 - Open
110.59 - Bid --
- Ask --
- Day's Range
109.26 - 112.13 - 52 Week Range
28.66 - 126.38 - Volume
-- - Avg. Volume
-- - Market Cap (intraday)
12.066B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
Statistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (5yr expected)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
--
-
Return on Assets (ttm)
--
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
--
-
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
-
Total Cash (mrq)
--
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
--
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
